About us
Our team
Our science
Radiopharmaceuticals
Our technology
Abstracts & publications
Our pipeline
News
Investors
Contact us
Radiopharm Theranostics
Click here for the latest stock information
Innovating the way we see and treat cancer
VIDEO
Radiopharm Theranostics panel discusses latest progress and understanding of radiopharmaceutical sector
PLAY
LATEST NEWS
RAD Invited to Participate in Jefferies Radiopharma Innovation Summit
Read more
Read more
LATEST NEWS
RAD Receives $1.56M R&D Tax Incentive
Read more
Read more
We are focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need.
Our technology
The unique potential of Radiopharmaceuticals in treating oncological diseases.
Learn more
Our pipeline
The unique potential of being
First to Market
or
Best in Class.
Learn more
Our team
We have a unique commitment to improve patients’ hope in fighting cancer.
Learn more
Information for investors
Stock price, Company governance & updates from our multiple development programs.
Learn more
Latest news
ASX Releases
RAD Invited to Participate in Jefferies Radiopharma Innovation Summit
March 28, 2023
Read more
Read more
ASX Releases
RAD Receives $1.56M R&D Tax Incentive
March 28, 2023
Read more
Read more
ASX Releases
RAD and GenesisCare Partner to Develop Novel Radiopharmaceuticals in Australia
March 27, 2023
Read more
Read more
Sign up to our mailing list.
Receive all the latest news from Radiopharm Theranostics.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form. Please fill out all starred fields.